Global Embolotherapy Market, By Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological and Nephrological Disorders and Gastrointestinal Disorders), Procedure (Trans catheter Arterial Embolization (TAE), Trans catheter Arterial Radio embolization (TARE)/ Selective Internal Radiation Therapy (SIRT) and Trans arterial Chemoembolization), End User (Hospitals and Clinics, Ambulatory Surgery Centres and Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.